PREVAIL U.S. primary and secondary lipid endpoints and lipoprotein particle analysis presented at the National Lipid Association Scientific Sessions SCOTTSDALE, Ariz., May 31, 2012 /PRNewswire via ...
In the intensive lipid-lowering group, LDL-cholesterol was reduced by 49%, achieving a median level of 62 mg/dL (1.6 mmol/L) during follow-up, compared with a 21% reduction in the standard therapy ...
Boca Raton, FL - A new meta-analysis of major pravastatin secondary-prevention trials has shown that the benefits from aspirin and statins are additive and may even be synergistic. The authors of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback